Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial (vol 386, pg 2404, 2015)

Lenze E. J.; Mulsant B. H.; Blumberger D. M.

首页> 外文期刊>The Lancet >Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial (vol 386, pg 2404, 2015)

【24h】

Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial (vol 386, pg 2404, 2015)

机译：阿立哌唑增强药物治疗晚期生命抗抑郁药的疗效，安全性和耐受性：一项随机，双盲，安慰剂对照试验（第386卷，第2404页，2015年）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Lancet》 |2015年第10011期|共1页
作者
Lenze E. J.; Mulsant B. H.; Blumberger D. M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献

1. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial (vol 386, pg 2404, 2015) [J] . Lenze E. J., Mulsant B. H., Blumberger D. M. The Lancet . 2015,第10011期

机译：阿立哌唑增强药物治疗晚期生命抗抑郁药的疗效，安全性和耐受性：一项随机，双盲，安慰剂对照试验（第386卷，第2404页，2015年）
2. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials. [J] . Mankoski Raymond, Eudicone James M, Marcus Ronald N, Journal of affective disorders . 2009,第1a2期

机译：阿立哌唑治疗精神分裂症的功效，安全性和耐受性：两项随机，双盲，安慰剂对照，关键性试验的受试者亚群汇总分析结果。
3. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence [J] . Rebecca McKetin, Olivia M. Dean, Alyna Turner, Trials . 2019,第1期

机译：N-ICE试验的研究方案：一种随机的双盲安慰剂对照研究N-乙酰半胱氨酸（NAC）作为甲基苯丙胺（“冰”）依赖的药物疗法的安全性和功效
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. Efficacy safety and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomized placebo-controlled trial [O] . Eric J. Lenze, Benoit H. Mulsant, Daniel M. Blumberger, -1

机译：阿立哌唑增强药物治疗晚期生命抗抑郁药的疗效安全性和耐受性：一项随机安慰剂对照试验
6. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study. [O] . Quigley, E M M, Vandeplassche, L, Kerstens, R, 2009

机译：临床试验：普卡洛必利在严重慢性便秘中的功效，对生活质量的影响以及安全性和耐受性-一项为期12周，随机，双盲，安慰剂对照的研究。

Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial (vol 386, pg 2404, 2015)

著录项

相似文献

相关主题

期刊订阅